- Brand names:
- Pharmaceutical Company:
- Condition/Indication:
- Meeting Date: July 2013
- Public Summary Document (PSD) July 2013 PBAC Meeting - PDF
Aflibercept – July 2013
Aflibercept, solution for IV injection, 100 mg/4 mL and 200 mg/8 mL, Zaltrap®
Last updated
8 November 2023